Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

GORBY LEON

Allopathic & Osteopathic Physicians Family Medicine

NPI
1679911762
CMS profile
1264437
Location
BYRON, GA

General Payments · PY2018–2024

$876.30

  • Reported across 49 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$287.46

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $287.46 15

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $100.20 5
Lilly USA, LLC $33.40 2
Sumitomo Pharma America, Inc. $33.19 2
Acerta Pharma LLC $31.26 2
ABBVIE INC. $28.45 1
DEXCOM, INC. $21.74 1
PFIZER INC. $19.87 1
Exact Sciences Corporation $19.35 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $147.99 10
PY2019 $63.19 4
PY2021 $72.20 4
PY2022 $67.08 4
PY2023 $238.38 12
PY2024 $287.46 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20182019202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $28.45 05/21/2024 Food and Beverage Undisputed 01/23/2026 1104162336 CMS
AstraZeneca Pharmaceuticals LP $17.61 09/10/2024 Food and Beverage Undisputed 01/23/2026 1104541930 CMS
AstraZeneca Pharmaceuticals LP $13.65 11/27/2024 Food and Beverage Undisputed 01/23/2026 1104451544 CMS
Dexcom, Inc. $21.74 01/18/2024 Food and Beverage Undisputed 01/23/2026 1153302039 CMS
Exact Sciences Corporation $19.35 07/11/2024 Food and Beverage Undisputed 01/23/2026 1114754380 CMS
Lilly USA, LLC $17.26 06/17/2024 Food and Beverage Undisputed 01/23/2026 1134978572 CMS
Lilly USA, LLC $16.14 07/30/2024 Food and Beverage Undisputed 01/23/2026 1135005499 CMS
Novo Nordisk Inc $22.75 01/16/2024 Food and Beverage Undisputed 01/23/2026 1097690235 CMS
Novo Nordisk Inc $19.50 04/02/2024 Food and Beverage Undisputed 01/23/2026 1096887116 CMS
Novo Nordisk Inc $14.15 06/05/2024 Food and Beverage Undisputed 01/23/2026 1096912952 CMS
Novo Nordisk Inc $21.29 09/24/2024 Food and Beverage Undisputed 01/23/2026 1096913484 CMS
Novo Nordisk Inc $22.51 10/17/2024 Food and Beverage Undisputed 01/23/2026 1096743580 CMS
PFIZER INC. $19.87 10/07/2024 Food and Beverage Undisputed 01/23/2026 1132067999 CMS
Sumitomo Pharma America, Inc. $18.13 06/26/2024 Food and Beverage Undisputed 01/23/2026 1148880748 CMS
Sumitomo Pharma America, Inc. $15.06 07/09/2024 Food and Beverage Undisputed 01/23/2026 1148880750 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.